BR9712705A - Composição para o tratamento da asma, contendo loratadina e um descongestionante - Google Patents
Composição para o tratamento da asma, contendo loratadina e um descongestionanteInfo
- Publication number
- BR9712705A BR9712705A BR9712705-1A BR9712705A BR9712705A BR 9712705 A BR9712705 A BR 9712705A BR 9712705 A BR9712705 A BR 9712705A BR 9712705 A BR9712705 A BR 9712705A
- Authority
- BR
- Brazil
- Prior art keywords
- asthma
- treatment
- decongestant
- composition
- containing loratadine
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 3
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003088 loratadine Drugs 0.000 title abstract 3
- 239000000850 decongestant Substances 0.000 title abstract 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 abstract 1
- 229960003908 pseudoephedrine Drugs 0.000 abstract 1
- 230000009325 pulmonary function Effects 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Patente de Invenção:<B>"COMPOSIçãO PARA O TRATAMENTO DA ASMA, CONTENDO LORATADINA E UM DESCONGESTIONANTE"<D>. A invenção engloba um processo para aperfeiçoamento da função pulmonar de um paciente sofrendo de asma, compreendendo a aplicação ao paciente com rinite usual, de quantidades eficazes de loratidina para o tratamento e um descongestionante tal como pseudoefedrina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73966996A | 1996-10-31 | 1996-10-31 | |
| PCT/US1997/019158 WO1998018470A1 (en) | 1996-10-31 | 1997-10-29 | Composition, for the treatment of asthma, containing loratadine and a decongestant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9712705A true BR9712705A (pt) | 1999-10-26 |
Family
ID=24973307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9712705-1A BR9712705A (pt) | 1996-10-31 | 1997-10-29 | Composição para o tratamento da asma, contendo loratadina e um descongestionante |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0941091A1 (pt) |
| JP (1) | JP2000505104A (pt) |
| KR (1) | KR20000052922A (pt) |
| CN (1) | CN1235545A (pt) |
| AR (1) | AR008908A1 (pt) |
| AU (1) | AU731756B2 (pt) |
| BR (1) | BR9712705A (pt) |
| CA (1) | CA2268546A1 (pt) |
| CO (1) | CO4910128A1 (pt) |
| CZ (1) | CZ150999A3 (pt) |
| HU (1) | HUP9904075A3 (pt) |
| ID (1) | ID23431A (pt) |
| IL (1) | IL129662A0 (pt) |
| NO (1) | NO992062L (pt) |
| NZ (1) | NZ335078A (pt) |
| PE (1) | PE11399A1 (pt) |
| PL (1) | PL333056A1 (pt) |
| SK (1) | SK54599A3 (pt) |
| TR (1) | TR199901003T2 (pt) |
| WO (1) | WO1998018470A1 (pt) |
| ZA (1) | ZA979731B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1205799A (en) * | 1997-10-29 | 1999-05-17 | J-Med Pharmaceuticals, Inc. | Antihistamine/decongestant regimens for treating rhinitis |
| US6132758A (en) | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
| IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| WO2000015226A1 (en) * | 1998-09-10 | 2000-03-23 | Schering Corporation | Antihistamines for treating non-infective sinusitis or otitis media |
| US6521254B2 (en) | 1998-12-07 | 2003-02-18 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
| KR100505899B1 (ko) * | 1999-02-23 | 2005-08-01 | 주식회사유한양행 | 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물 |
| CN1161112C (zh) * | 1999-02-23 | 2004-08-11 | 株式会社柳韩洋行 | 含氯雷他定和伪麻黄碱的药物胶囊组合物 |
| WO2000057880A1 (en) * | 1999-03-29 | 2000-10-05 | Schering Corporation | Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine |
| AU2276801A (en) * | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
| AU2277101A (en) * | 1999-12-20 | 2001-07-03 | Schering Corporation | Stable extended release oral dosage composition |
| CA2405238C (en) * | 2000-04-14 | 2014-03-18 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
| PA8517201A1 (es) * | 2000-05-25 | 2002-08-26 | Schering Corp | Composiciones farmaceuticas antihistaminicas anticongestivas liquidas estables |
| MXPA03011705A (es) * | 2001-06-20 | 2004-03-19 | Schering Corp | Antihistaminas para el tratamiento de congestion nasal y obstruccion nasal. |
| RU2423979C2 (ru) * | 2005-06-17 | 2011-07-20 | АФТ Фармасьютикалз Лимитед | Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей |
| PL1896022T3 (pl) * | 2005-06-17 | 2013-03-29 | Aft Pharmaceuticals Ltd | Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowych |
| NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
| AU2007254821B2 (en) * | 2006-06-01 | 2013-11-14 | Bayer Consumer Care Ag | Sustained release pharmaceutical formulation comprising phenylephrine |
| KR101540191B1 (ko) * | 2014-02-24 | 2015-07-28 | 성균관대학교산학협력단 | 로라타딘을 포함하는 항염증용 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1110397A (en) * | 1964-10-02 | 1968-04-18 | Mead Johnson & Co | Ephedrine composition |
| US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
| US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
| US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
-
1997
- 1997-10-29 BR BR9712705-1A patent/BR9712705A/pt not_active Application Discontinuation
- 1997-10-29 CN CN97199404A patent/CN1235545A/zh active Pending
- 1997-10-29 AR ARP970105033A patent/AR008908A1/es not_active Application Discontinuation
- 1997-10-29 SK SK545-99A patent/SK54599A3/sk unknown
- 1997-10-29 JP JP10520579A patent/JP2000505104A/ja active Pending
- 1997-10-29 NZ NZ335078A patent/NZ335078A/xx unknown
- 1997-10-29 CA CA002268546A patent/CA2268546A1/en not_active Abandoned
- 1997-10-29 KR KR1019990703790A patent/KR20000052922A/ko not_active Ceased
- 1997-10-29 CZ CZ991509A patent/CZ150999A3/cs unknown
- 1997-10-29 ID IDW990280D patent/ID23431A/id unknown
- 1997-10-29 EP EP97912874A patent/EP0941091A1/en not_active Withdrawn
- 1997-10-29 IL IL12966297A patent/IL129662A0/xx unknown
- 1997-10-29 WO PCT/US1997/019158 patent/WO1998018470A1/en not_active Ceased
- 1997-10-29 PE PE1997000968A patent/PE11399A1/es not_active Application Discontinuation
- 1997-10-29 CO CO97063641A patent/CO4910128A1/es unknown
- 1997-10-29 PL PL97333056A patent/PL333056A1/xx unknown
- 1997-10-29 HU HU9904075A patent/HUP9904075A3/hu unknown
- 1997-10-29 ZA ZA9709731A patent/ZA979731B/xx unknown
- 1997-10-29 AU AU49953/97A patent/AU731756B2/en not_active Ceased
- 1997-10-29 TR TR1999/01003T patent/TR199901003T2/xx unknown
-
1999
- 1999-04-29 NO NO992062A patent/NO992062L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1235545A (zh) | 1999-11-17 |
| IL129662A0 (en) | 2000-02-29 |
| ZA979731B (en) | 1998-04-29 |
| AU4995397A (en) | 1998-05-22 |
| HUP9904075A2 (hu) | 2000-05-28 |
| HUP9904075A3 (en) | 2002-02-28 |
| SK54599A3 (en) | 2000-08-14 |
| PL333056A1 (en) | 1999-11-08 |
| AR008908A1 (es) | 2000-02-23 |
| AU731756B2 (en) | 2001-04-05 |
| JP2000505104A (ja) | 2000-04-25 |
| EP0941091A1 (en) | 1999-09-15 |
| PE11399A1 (es) | 1999-02-09 |
| CZ150999A3 (cs) | 1999-10-13 |
| WO1998018470A1 (en) | 1998-05-07 |
| TR199901003T2 (xx) | 1999-07-21 |
| NZ335078A (en) | 2000-10-27 |
| KR20000052922A (ko) | 2000-08-25 |
| CA2268546A1 (en) | 1998-05-07 |
| ID23431A (id) | 2000-04-20 |
| NO992062D0 (no) | 1999-04-29 |
| CO4910128A1 (es) | 2000-04-24 |
| NO992062L (no) | 1999-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712705A (pt) | Composição para o tratamento da asma, contendo loratadina e um descongestionante | |
| EP1007556A4 (en) | TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS | |
| BRPI0109131B8 (pt) | dna, vetor de expressão compreendendo o mesmo, fator viii modificado de porcino, seu processo de produção e composição terapêutica compreendendo o mesmo | |
| BR0009480A (pt) | Soluções de poliuretano com unidades de estrutura de alcoxissilano | |
| BR9911666A (pt) | Combinação farmacêutica, uso da combinação, processo para tratamento de uma doença inflamatória em uma pessoa sofrendo de ou susceptìvel a tal doença, e, composição farmacêutica | |
| FI965203A7 (fi) | Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus | |
| FI962990L (fi) | Menetelmä rekombinanttisten adenovirukseen assosioituvien virusten (AAV:iden) valmistamiseksi ja sen käyttöjä | |
| ITMI941252A0 (it) | Composizione catalitica e processo per l'alchilazione di composti aromatici | |
| ID30385A (id) | Komposisi penghilang infeksi berbahan dasar h202, asam dan ion-ion logam | |
| IT1290846B1 (it) | Composizione catalitica e processo per l'alchilazione e/o la transalchilazione di composti aromatici | |
| EP1001782A4 (en) | 5,6-HETEROARYL-DIPYRIDO 2,3- $ i (b): 3 ', 2' - $ i (f)] AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION | |
| CA2304657A1 (en) | Treatment of conduct disorder | |
| IL140118A0 (en) | Use of optically pure (+) norcisapride for treating apnea, bulimia and other disorders | |
| BR9809022A (pt) | Composições antiinflamatórias nasais tópicas | |
| BR9710390B1 (pt) | processo para preparação de sìlica compatìvel com aromatizantes, utilização da sìlica, e, composição dentifrìcia. | |
| BR9913072A (pt) | Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia | |
| BR9813996A (pt) | 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio | |
| PE118999A1 (es) | Composiciones y metodos para tratar trastornos respiratorios | |
| BR9911917A (pt) | Composições compreendendo análogos de gaba e cafeìna | |
| BR9914848A (pt) | Composição e processo para o tratamento de distúrbios da retina externa | |
| DE69411726D1 (de) | Zusammensetzungen zur freigabe einer aromatischen substanz in die nase | |
| BR0103710A (pt) | Proteção de fibras queratinosas usando ceramidas e/ou glicoceramidas | |
| BR8806062A (pt) | Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis | |
| BR0113650A (pt) | N-(3,5-dicloro-2-metoxifenil)-4-metóxi-3-piperazina-1-il a-benzenossulfonamida | |
| BR9712767A (pt) | Expressão especìfica para tecido de proteìna de retinoblastoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |